{{'Sat, 07 Dec 2024 11:30:00 -0500' | dateFormatUsFilter}}
Phase 2 data from the ongoing HIBISCUS study shows promise that investigational etavopivat could reduce the incidence of vaso-occlusive crises in people with sickle cell disease
Read more
{{'Thu, 05 Dec 2024 08:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk to lower US list prices for Tresiba® and Fiasp® by more than 70%
Read more
{{'Tue, 03 Dec 2024 08:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.